BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4465730)

  • 1. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin.
    Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H
    Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum levels of insulin-binding antibodies treated with monocomponent insulin].
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proceedings: 2 years of experiences with monocomponent insulin in diabetic patients].
    Fankhauser S; Michl J; Morell B
    Helv Med Acta; 1974 May; 37(5-6):365-6. PubMed ID: 4605883
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic response to mono-component insulin in newly diagnosed diabetic patients.
    Devlin JG; Parameswaran V
    Ir Med J; 1975 Jun; 68(12):301-5. PubMed ID: 1140940
    [No Abstract]   [Full Text] [Related]  

  • 7. [Insulin-binding antibodies and insulin resistance (author's transl)].
    Waldhäusl W
    Wien Klin Wochenschr; 1973 Dec; 85(51):833-6. PubMed ID: 4272340
    [No Abstract]   [Full Text] [Related]  

  • 8. [Factors affecting the antigenicity of exogenous insulin in diabetics].
    Penchev II; Taneva T; Ditsov S; Andreev D
    Vutr Boles; 1985; 24(1):113-9. PubMed ID: 3895740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
    Bruni B; Bruni Bocher K; Gamba S; Giolitti A; Rittatore R; Turco GL
    Panminerva Med; 1977; 19(4):247-54. PubMed ID: 593701
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications.
    Andreani D; Iavicoli M; Tamburrano G; Menzinger G; Maltarello C
    Horm Metab Res; 1974 Nov; 6(6):447-54. PubMed ID: 4476720
    [No Abstract]   [Full Text] [Related]  

  • 13. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
    Göbel P; Kramer W; Heni F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
    [No Abstract]   [Full Text] [Related]  

  • 14. A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects.
    Sebriakova M; Little JA
    Diabetes; 1973 Jan; 22(1):30-40. PubMed ID: 4734254
    [No Abstract]   [Full Text] [Related]  

  • 15. [The study of insulin antibodies in different forms of diabetes mellitus].
    Mincu I; Ionescu-Tirgovişte C; Cheţa D; Simionescu L; Mirodon Z; Vasilescu V; Bruckner I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):421-8. PubMed ID: 44565
    [No Abstract]   [Full Text] [Related]  

  • 16. Human insulin.
    Roberts RJ
    Iowa Med; 1984 Mar; 74(3):116-8. PubMed ID: 6373658
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with monocomponent insulin treatment].
    Korp W; Levett RE
    Wien Klin Wochenschr; 1973 May; 85(18):326-30. PubMed ID: 4699490
    [No Abstract]   [Full Text] [Related]  

  • 18. C-peptide antibodies induced by bovine insulin therapy.
    Reeves WG; Douglas CA
    Clin Exp Immunol; 1982 Oct; 50(1):171-7. PubMed ID: 6756729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of antibody to monocomponent insulin in guinea pigs.
    Okada S; Kawanishi K; Ofuji T
    Acta Med Okayama; 1974 Oct; 28(5):377-8. PubMed ID: 4281999
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunogenicity of MC Lente Novo insulin].
    Rogala H; Lawecki J; Czyzyk A
    Pol Arch Med Wewn; 1986 Sep; 76(3):172-6. PubMed ID: 3554163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.